US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Corgi Beauty, Skincare & Aesthetics ETF

28.45

+0.34251.22%

Volume:310

Turnover:8.82K

Market Cap:1.42M

PE:- -

High:28.45

Open:28.45

Low:28.45

Close:28.11

52wk High:29.89

52wk Low:24.32

Shares:50.00K

Float Shares:50.00K

Volume Ratio:3.85

T/O Rate:0.62%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

AbbVie’s ECLIPSE Migraine Trial Completes, Setting Up a New Catalyst for ABBV

Hims & Hers Health Price Target Announced at $32.00/Share by JP Morgan

Deutsche sees Estee shares topping $120 by year-end in ‘bull case’

Analysts’ Top Healthcare Picks: Adagene (ADAG), AbbVie (ABBV)

Align Technology Inc. Stock Outperforms Competitors Despite Losses on the Day

Estée Lauder Director Charlene Barshefsky Disposes of 3,775 Common Shares Worth $372,046.5

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

AbbVie Declares Quarterly Cash Dividend of $1.73 a Share

Abbvie - Declares Qtrly Cash Dividend of $1.73 Per Share

THOMSON REUTERS

AbbVie’s Eye Implant Study Delivers Fresh Real‑World Clarity for Investors

AbbVie Says Atogepant Met Primary, Secondary Endpoints in Phase 3 Menstrual Migraine Study

MT Newswires Live

AbbVie’s atogepant shows positive Phase 3 results in menstrual migraine

Abbvie - Atogepant Safety Results Consistent with Known Profile; no New Safety Signals

THOMSON REUTERS

Abbvie - Atogepant Meets Primary and All Eight Ranked Secondary Endpoints in Phase 3 Luna Study

THOMSON REUTERS

Abbvie Extends Migraine Leadership with Positive Phase 3 Atogepant Results in Menstrual Migraine

THOMSON REUTERS

Abbvie - Atogepant Shows Significant Improvements Across Multiple Endpoints Versus Placebo

THOMSON REUTERS

Kenvue Keeps Quarterly Dividend to $0.21 a Share; Payable Oct. 2 to Holders of Record Sept. 21

MT Newswires Live

Kenvue Declares Quarterly Dividend of $0.21 Per Share

Kenvue - Declares Qtrly Cash Dividend of $0.21 Per Share

THOMSON REUTERS

Abbvie Exec Says Strong Balance Sheet and Long Growth Runway Allow Company to Consider Both Early- and Late-Stage Business Development Opportunities - Conf Call

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/GLAM/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GLAM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLAM\",,,,,undefined,":{"symbol":"GLAM","market":"US","secType":"STK","nameCN":"Corgi Beauty, Skincare & Aesthetics ETF","latestPrice":28.45,"timestamp":1791568423270,"preClose":28.1075,"halted":0,"volume":310,"delay":0,"changeRate":0.012185359779418217,"floatShares":50000,"shares":50000,"eps":0,"marketStatus":"Trading","change":0.3425,"latestTime":"10-09 13:57:34 EDT","open":28.45,"high":28.45,"low":28.4499,"amount":8818.467700000001,"amplitude":0.000004,"askPrice":28.51,"askSize":1400,"bidPrice":28.46,"bidSize":1400,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791576000000},"marketStatusCode":2,"adr":0,"exchange":"CBOE","adjPreClose":28.1075,"nav":28.05,"aum":1402500,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":28.0701,"preClose":28.1075,"latestTime":"16:15 EDT","volume":8,"amount":224.86,"timestamp":1791490500331,"change":-0.0374,"changeRate":-0.001331,"amplitude":0},"volumeRatio":3.849139,"impliedVol":0.0781,"impliedVolPercentile":0.09},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLAM\",,,,,undefined,":{"symbol":"GLAM","floatShares":50000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":3.849139,"shares":50000,"dividePrice":0,"high":28.45,"amplitude":0.000004,"preClose":28.1075,"low":28.4499,"week52Low":24.3178,"pbRate":"--","week52High":29.89,"institutionHeld":0,"latestPrice":28.45,"eps":0,"divideRate":0,"volume":310,"delay":0,"ttmEps":0,"open":28.45,"prevYearClose":25.82,"prevWeekClose":27.6182,"prevMonthClose":27.766,"prevQuarterClose":27.766,"fiveDayClose":27.6182,"twentyDayClose":28.0254,"sixtyDayClose":27.8939},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GLAM\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GLAM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GLAM\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GLAM\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666575717","title":"AbbVie’s ECLIPSE Migraine Trial Completes, Setting Up a New Catalyst for ABBV","url":"https://stock-news.laohu8.com/highlight/detail?id=2666575717","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666575717?lang=en_us&edition=fundamental","pubTime":"2026-09-12 00:30","pubTimestamp":1789144218,"startTime":"0","endTime":"0","summary":"Abbvie ($ABBV) announced an update on their ongoing clinical study. The AbbVie Inc. (ABBV) ECLIPSE study, officially titled “Randomized, Double-bli...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvies-eclipse-migraine-trial-completes-setting-up-a-new-catalyst-for-abbv?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvies-eclipse-migraine-trial-completes-setting-up-a-new-catalyst-for-abbv?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABBV","LU0432979614.USD","LU0511384066.AUD","LU1093756168.USD","LU2129689514.USD","LU1267930490.SGD","VHT","TRUH","LU1023059063.AUD","IE00BBT3K403.USD","LU1244550577.SGD","LU0965508806.USD","JDOC","LU1236620834.HKD","LU1430594728.SGD","LU0170899867.USD","GLAM","LU1670628061.USD","IE00BJT1NW94.SGD","PPH","AGNG","IE000SO60NU8.SGD","IE00BJJMRZ35.SGD","FHLC","LU2347655156.SGD","LU1162221912.USD","LU1057294990.SGD","LU0057025933.USD","IE00BSNM7G36.USD","LU0965509010.AUD","LU2089283258.USD","SG9999015952.SGD","LU1983299246.USD","LU2347655073.USD","IYH","LU1989772923.USD","LU0122379950.USD","RXL","FTXH","IE000WAW04H5.SGD","IXJ","SG9999003800.SGD","XLV","PJP","LU0738911758.USD","LU0861579265.USD","IE000BZT7R73.USD","MEDX","LU1496350171.SGD","IE000MB6IJN5.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666774524","title":"Hims & Hers Health Price Target Announced at $32.00/Share by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2666774524","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666774524?lang=en_us&edition=fundamental","pubTime":"2026-09-11 20:37","pubTimestamp":1789130220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HIMS/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLAM","HMYY","HIMY","HIMZ","BK4196","HIMS","HEAL","HIYY","HIMC","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666228245","title":"Deutsche sees Estee shares topping $120 by year-end in ‘bull case’","url":"https://stock-news.laohu8.com/highlight/detail?id=2666228245","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666228245?lang=en_us&edition=fundamental","pubTime":"2026-09-11 20:35","pubTimestamp":1789130111,"startTime":"0","endTime":"0","summary":"Deutsche Bank analyst Steve Powers sees a credible “bull case” path for Estee Lauder (EL) shares to exceed $120 by the end of 2026 and closer to $1...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/deutsche-sees-estee-shares-topping-120-by-year-end-in-bull-case-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/deutsche-sees-estee-shares-topping-120-by-year-end-in-bull-case-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU1064131342.USD","BK4548","LU2552382058.USD","LU0690374961.EUR","LU1988902786.USD","BK4588","BK4566","GLAM","EL","BK4552","LU2552382215.SGD","LU2264538146.SGD","LU2552382132.HKD","LU0690374615.EUR","LU2404859667.USD","BK4558","BK4183","DB","LU2404859741.USD","BK4533","BK4118","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666216595","title":"Analysts’ Top Healthcare Picks: Adagene (ADAG), AbbVie (ABBV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666216595","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666216595?lang=en_us&edition=fundamental","pubTime":"2026-09-11 19:40","pubTimestamp":1789126806,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Adagene (ADAG), AbbVie (ABBV) and Definium Therapeut...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-adagene-adag-abbvie-abbv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-adagene-adag-abbvie-abbv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLAM","LU2125909247.SGD","IE0009355771.USD","MEDX","ABBV","RXL","IE0002270589.USD","LU0726765562.USD","IXJ","LU0795875169.SGD","SG9999011175.SGD","IE0004445239.USD","BK4559","LU1074936037.SGD","LU1983299246.USD","PJP","XBI","FHLC","IYH","PPH","LU2023251221.USD","LU0289739699.SGD","LU0689626769.HKD","IE00B2B36J28.USD","XLV","JDOC","AGNG","LU0098860793.USD","LU0661504455.SGD","LU1037948897.HKD","IE0002141913.USD","LU1732799900.SGD","LU1057294990.SGD","LABU","LU1934455863.HKD","VHT","TRUH","LU2347655073.USD","IE00BFTCPJ56.SGD","LU0820561818.USD","LU1061106388.HKD","ADAG","IE00B42XCP33.USD","LU0417517546.SGD","LU1496350502.SGD","LU2433249047.HKD","HCSG","LU1923622614.USD","LU0708994859.HKD","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666516488","title":"Align Technology Inc. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2666516488","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666516488?lang=en_us&edition=fundamental","pubTime":"2026-09-11 05:16","pubTimestamp":1789074960,"startTime":"0","endTime":"0","summary":"DJ Align Technology Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Align Technology Inc.  slipped 1.44% to $150.72 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.58% to 7,591.70 and Dow Jones Industrial Average  falling 0.60% to 52,064.10.This was the stock's fourth consecutive day of losses.Align Technology Inc. closed 24.80% short of its 52-week high of $200.44, which the company reached on April 21st.Despite its losses, the stock outperformed some of its competitors Thursday, as Zimmer Biomet Holdings Inc.  fell 2.29% to $92.44 and Dentsply Sirona Inc.  fell 2.05% to $10.50.Trading volume  remained 84,450 below its 50-day average volume of 920,506.Data source: Dow Jones Market Data, FactSet. Data compiled September 10, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0130517989.USD","LU0792757196.USD","LU0128525929.USD","LU0310799852.SGD","GLAM","LU2023250504.SGD","LU0029864427.USD","LU0006061336.USD","BK4082","LU2106854487.HKD","LU0211328371.USD","BK4504","BK4534","IE00B19Z3581.USD","LU1974910355.USD","BK4588","LU0889566641.SGD","IE0002270589.USD","BK4198","LU2023250843.SGD","LU0477156953.USD","LU1267930813.SGD","LU1917777945.USD","IE00B7SZLL34.SGD","LU1201861249.SGD","ALGN","ZBH","XRAY","LU0130102774.USD","BK4585","LU1267930573.SGD","LU0211327993.USD","BK4566","IE00B19Z3B42.SGD","LU0980610538.SGD","LU0648001328.SGD","LU0310800379.SGD","LU0708994859.HKD","LU1267930490.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666151681","title":"Estée Lauder Director Charlene Barshefsky Disposes of 3,775 Common Shares Worth $372,046.5","url":"https://stock-news.laohu8.com/highlight/detail?id=2666151681","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666151681?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:43","pubTimestamp":1789073010,"startTime":"0","endTime":"0","summary":"Estée Lauder director Charlene Barshefsky disposes of 3,775 common shares worth $372,046.5Estée Lauder director Charlene Barshefsky sold 3,775 Class A common shares at USD 98.82 on Sept. 9.The filing ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL6rJt8t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Estée Lauder Director Charlene Barshefsky Disposes of 3,775 Common Shares Worth $372,046.5","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","GLAM","BK4558","BK4585","LU2404859667.USD","LU2552382215.SGD","BK4588","BK4533","BK4504","BK4548","LU0690374961.EUR","LU0690374615.EUR","EL","LU2404859741.USD","LU2264538146.SGD","LU1988902786.USD","LU2552382058.USD","LU2552382132.HKD","LU1064131342.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666515425","title":"AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2666515425","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666515425?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:31","pubTimestamp":1789072260,"startTime":"0","endTime":"0","summary":"DJ AbbVie Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of AbbVie Inc.  rallied 1.63% to $255.00 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.58% to 7,591.70 and Dow Jones Industrial Average  falling 0.60% to 52,064.10.This was the stock's second consecutive day of gains.AbbVie Inc. closed 4.66% below its 52-week high of $267.47, which the company reached on July 29th.The stock outperformed some of its competitors Thursday, as Johnson & Johnson  fell 0.27% to $266.35, Pfizer Inc.  fell 0.47% to $27.65, and Amgen Inc.  fell 2.25% to $382.47.Trading volume  remained 922,509 below its 50-day average volume of 5.3 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 10, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0943347566.SGD","LU1057294990.SGD","LU2089284900.SGD","IE00BSNM7G36.USD","IE00B42XCP33.USD","LU2125909247.SGD","LU0511384066.AUD","LU0965509010.AUD","LU1551013342.USD","LU1934455863.HKD","LU0868494708.USD","LU0689472784.USD","IE000BZT7R73.USD","BK4559","LU1989771016.USD","LU0553294199.USD","LU0689626769.HKD","LU1496350502.SGD","LU2237443382.USD","IE0004445239.USD","LU0310800379.SGD","LU1929549753.HKD","MEDX","IE0002141913.USD","LU1003077747.HKD","LU1989772840.SGD","IE00B2B36J28.USD","LU0203347892.USD","LU0472753341.HKD","LU1244550221.USD","LU2112291526.USD","LU1023059063.AUD","SG9999003800.SGD","LU0795875169.SGD","LU1236620750.USD","FTXH","BK4533","LU0057025933.USD","LU1585245621.USD","BK4139","LU1037948897.HKD","IE000MB6IJN5.SGD","LU0198837287.USD","LU0456855351.SGD","LU1074936037.SGD","IE00BJJMRZ35.SGD","SG9999015945.SGD","SG9999015986.USD","LU2237443549.SGD","SG9999011175.SGD","LU0124676726.USD","LU2237443465.HKD","LU2129689605.HKD","LU2347655156.SGD","GLAM","IE00BLSP4239.USD","LU0868494617.USD","BK4585","VHT","LU0820561909.HKD","LU1551013425.SGD","LU1934455194.USD","LU1983299246.USD","LU1267930573.SGD","LU0203345920.USD","LU0726765562.USD","LU0820561818.USD","IE00B19Z3B42.SGD","LU0395794307.EUR","LU1989772923.USD","LU1430594728.SGD","LU0545039389.USD","LU2347655073.USD","JDOC","LU2133065610.SGD","IE0009355771.USD","LU1037948541.HKD","LU0234572021.USD","LU0861579265.USD","XLV","LU1923622614.USD","IE00BVYPNV92.GBP","LU0211328371.USD","IE00B4R5TH58.HKD","BK4588","IE00BFTCPJ56.SGD","BK4566","LU0289739699.SGD","PPH","LU0211327993.USD","LU1093756325.SGD","FHLC","LU2237443895.HKD","LU2468319806.SGD","LU2125909593.SGD","BK4534","LU2433249047.HKD","LU0985320562.USD","IE000F7OJYX1.SGD","LU0417517546.SGD","IE00BDGV0183.EUR","IE00BLSP4452.SGD","LU0708994859.HKD","LU2357627491.SGD","LU0965509283.SGD","LU0114720955.EUR","LU0289739343.SGD","LU0289961442.SGD","LU0128525929.USD","LU0859254822.USD","LU1670627923.USD","LU0256863811.USD","IE00BGHQF631.EUR","LU1496350171.SGD","LU1162221912.USD","LU0234570918.USD","LU1718418525.SGD","LU0738911758.USD","IE000SO60NU8.SGD","IE000WAW04H5.SGD","LU0058720904.USD","LU0823416689.USD","LU0029864427.USD","LU0310799852.SGD","LU0912757837.SGD","IE00B3PB1722.GBP","LU0965508806.USD","LU1839511570.USD","LU1244550494.USD","LU2087621335.USD","AGNG","IE00BBT3K403.USD","LU0942090050.USD","LU0882574055.USD","LU0320765646.SGD","LU0256863902.USD","LU1061106388.HKD","LU1244550577.SGD","LU0795875086.SGD","LU2089984988.USD","LU1236620834.HKD","IE0002270589.USD","LU1670628061.USD","LU1093756168.USD","SG9999015952.SGD","LU2023251221.USD","LU2089283258.USD","LU0432979614.USD","IE00BVYPNW00.USD","LU1934455277.USD","LU1267930490.SGD","LU0122379950.USD","LU0170899867.USD","SG9999015978.USD","ABBV","BK4581","IYH","LU1732800096.USD","SG9999001440.SGD","IE0000B7K699.USD","LU1291159041.SGD","RXL","TRUH","BK4550","LU2237443622.USD","LU0158827948.USD","LU0949170772.SGD","LU2129689514.USD","LU2237443978.SGD","LU2129689431.USD","LU0965509101.SGD","LU0098860793.USD","LU0661504455.SGD","IE00BJT1NW94.SGD","LU1732799900.SGD","PJP","IXJ","IE00BN8TJ469.HKD","LU0069063385.USD","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666107590","title":"AbbVie Declares Quarterly Cash Dividend of $1.73 a Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2666107590","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666107590?lang=en_us&edition=fundamental","pubTime":"2026-09-11 02:18","pubTimestamp":1789064322,"startTime":"0","endTime":"0","summary":"AbbVie declares quarterly cash dividend of $1.73 a shareAbbVie declared a quarterly cash dividend of $1.73 per share.Dividend payable Nov. 16, 2026, to stockholders of record as of Oct. 15, 2026.Discl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL5lD9cS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BVYPNW00.USD","LU1923622614.USD","RXL","LU2089283258.USD","LU1839511570.USD","LU1093756325.SGD","LU0820561818.USD","LU1003077747.HKD","LU2237443622.USD","GLAM","LU2129689514.USD","LU1037948897.HKD","XLV","LU1244550221.USD","LU0689472784.USD","MEDX","VHT","LU0289739343.SGD","IE00B4R5TH58.HKD","IYH","FTXH","LU1244550577.SGD","BK4588","IXJ","PPH","LU2089284900.SGD","LU1023059063.AUD","LU2112291526.USD","IE0002141913.USD","IE00BJT1NW94.SGD","SG9999001440.SGD","PJP","LU2433249047.HKD","TRUH","ABBV","LU0965509010.AUD","JDOC","LU2133065610.SGD","LU2129689431.USD","FHLC","LU2237443382.USD","LU0985320562.USD","LU0738911758.USD","LU1430594728.SGD","LU0211327993.USD","LU0472753341.HKD","LU0234570918.USD","LU2125909593.SGD","AGNG","LU1496350171.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666590101","title":"Abbvie - Declares Qtrly Cash Dividend of $1.73 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2666590101","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666590101?lang=en_us&edition=fundamental","pubTime":"2026-09-11 02:18","pubTimestamp":1789064315,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nFWN4520NY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765646.SGD","FHLC","AGNG","IE000WAW04H5.SGD","IE00BLSP4239.USD","GLAM","LU1236620834.HKD","BK4550","IE0002270589.USD","LU2237443465.HKD","LU1057294990.SGD","SG9999015978.USD","IXJ","LU1162221912.USD","ABBV","JDOC","LU0511384066.AUD","LU2125909593.SGD","PPH","LU2112291526.USD","LU1732799900.SGD","MEDX","BK4588","LU0310800379.SGD","VHT","LU1496350502.SGD","IYH","PJP","SG9999015945.SGD","LU0949170772.SGD","LU1074936037.SGD","LU1983299246.USD","IE000BZT7R73.USD","BK4139","LU1093756325.SGD","LU2087621335.USD","LU1244550577.SGD","LU0069063385.USD","RXL","XLV","LU0310799852.SGD","LU1496350171.SGD","LU0985320562.USD","BK4581","LU2468319806.SGD","TRUH","LU0868494708.USD","LU2237443622.USD","FTXH","LU1267930573.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666973105","title":"AbbVie’s Eye Implant Study Delivers Fresh Real‑World Clarity for Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666973105","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666973105?lang=en_us&edition=fundamental","pubTime":"2026-09-11 00:30","pubTimestamp":1789057812,"startTime":"0","endTime":"0","summary":"Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie is reporting new data from an observational eye study in adults with dia...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvies-eye-implant-study-delivers-fresh-realworld-clarity-for-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvies-eye-implant-study-delivers-fresh-realworld-clarity-for-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BBT3K403.USD","IE000F7OJYX1.SGD","LU0726765562.USD","VHT","LU2468319806.SGD","LU1003077747.HKD","LU1496350171.SGD","LU0738911758.USD","LU1244550221.USD","LU0256863811.USD","FTXH","LU0795875169.SGD","LU1839511570.USD","AGNG","IE00BDGV0183.EUR","LU0256863902.USD","LU0820561818.USD","LU1585245621.USD","PJP","RXL","IXJ","LU2089284900.SGD","IE00BJT1NW94.SGD","LU2237443895.HKD","LU2433249047.HKD","PPH","LU0320765646.SGD","IE00B2B36J28.USD","IE0002141913.USD","LU1074936037.SGD","IE00B4R5TH58.HKD","ABBV","IYH","LU0203345920.USD","LU1061106388.HKD","LU2347655156.SGD","MEDX","LU0057025933.USD","LU0417517546.SGD","BK4534","LU0234570918.USD","GLAM","JDOC","IE00BJJMRZ35.SGD","ISBC","LU0868494617.USD","XLV","TRUH","LU0211328371.USD","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666596073","title":"AbbVie Says Atogepant Met Primary, Secondary Endpoints in Phase 3 Menstrual Migraine Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2666596073","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666596073?lang=en_us&edition=fundamental","pubTime":"2026-09-10 21:30","pubTimestamp":1789047005,"startTime":"0","endTime":"0","summary":"AbbVie (ABBV) said Thursday that atogepant for the preventive treatment of menstrual migraine in adults met its primary and all eight ranked secondary endpoints in the Phase 3 LUNA study.Atogepant dem","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1244550577.SGD","RXL","IE00BJT1NW94.SGD","TRUH","LU1061106388.HKD","LU2347655156.SGD","LU0820561909.HKD","LU1037948897.HKD","LU0882574055.USD","SG9999003800.SGD","GLAM","LU2125909247.SGD","LU2237443622.USD","LU0708994859.HKD","IE00BLSP4452.SGD","IXJ","LU1934455863.HKD","LU0820561818.USD","LU0395794307.EUR","LU2129689514.USD","AGNG","IE00B19Z3B42.SGD","LU0985320562.USD","LU1244550221.USD","FTXH","IE00BSNM7G36.USD","LU0965509101.SGD","SG9999001440.SGD","BK4534","FHLC","LU1236620834.HKD","XLV","PJP","IYH","JDOC","VHT","LU0211328371.USD","SG9999015986.USD","IE00BVYPNV92.GBP","IE00BLSP4239.USD","LU0511384066.AUD","PPH","LU0029864427.USD","LU0912757837.SGD","ABBV","MEDX","LU1496350171.SGD","IE0004445239.USD","LU0456855351.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666596813","title":"AbbVie’s atogepant shows positive Phase 3 results in menstrual migraine","url":"https://stock-news.laohu8.com/highlight/detail?id=2666596813","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666596813?lang=en_us&edition=fundamental","pubTime":"2026-09-10 21:00","pubTimestamp":1789045214,"startTime":"0","endTime":"0","summary":"AbbVie (ABBV) announced positive topline results from the Phase 3 LUNA study, which evaluated atogepant, a calcitonin gene-related peptide, or CGRP...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abbvies-atogepant-shows-positive-phase-3-results-in-menstrual-migraine-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abbvies-atogepant-shows-positive-phase-3-results-in-menstrual-migraine-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2237443382.USD","LU0203345920.USD","VHT","IE00BBT3K403.USD","BK4550","LU0114720955.EUR","AGNG","ABBV","IE0000B7K699.USD","LU0726765562.USD","FHLC","LU0256863811.USD","GLAM","LU0859254822.USD","LU1989772923.USD","BK4534","XLV","BK4139","LU1670628061.USD","LU1236620834.HKD","LU0949170772.SGD","RXL","IE00BN8TJ469.HKD","LU0965508806.USD","LU0170899867.USD","LU1057294990.SGD","BK4581","LU0795875086.SGD","IE00B2B36J28.USD","LU2089984988.USD","IE000MB6IJN5.SGD","MEDX","PJP","LU1934455863.HKD","LU2237443465.HKD","LU0661504455.SGD","LU0823416689.USD","IE00BSNM7G36.USD","TRUH","IYH","LU0553294199.USD","BK4588","LU0289739699.SGD","LU2357627491.SGD","IE00BFTCPJ56.SGD","JDOC","LU0128525929.USD","PPH","FTXH","IXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666954045","title":"Abbvie - Atogepant Safety Results Consistent with Known Profile; no New Safety Signals","url":"https://stock-news.laohu8.com/highlight/detail?id=2666954045","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666954045?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:55","pubTimestamp":1789044900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA8RPXBH:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4559","LU1496350171.SGD","PPH","LU0456855351.SGD","LU1934455194.USD","LU1732800096.USD","LU1929549753.HKD","JDOC","AGNG","IE00BDGV0183.EUR","MEDX","LU2125909593.SGD","LU0124676726.USD","RXL","LU0689626769.HKD","LU0820561909.HKD","VHT","IXJ","LU0158827948.USD","BK4581","LU0170899867.USD","LU0417517546.SGD","IE00BN8TJ469.HKD","FHLC","FTXH","LU0545039389.USD","TRUH","SG9999001440.SGD","LU2125909247.SGD","IE000BZT7R73.USD","LU2133065610.SGD","LU1244550494.USD","LU1989772923.USD","IYH","LU0949170772.SGD","GLAM","LU0726765562.USD","LU0289961442.SGD","IE00BGHQF631.EUR","LU1267930573.SGD","XLV","LU2433249047.HKD","LU0289739343.SGD","SG9999015986.USD","IE00BLSP4239.USD","PJP","SG9999015978.USD","LU0965508806.USD","ABBV","LU1291159041.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666595402","title":"Abbvie - Atogepant Meets Primary and All Eight Ranked Secondary Endpoints in Phase 3 Luna Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2666595402","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666595402?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:55","pubTimestamp":1789044900,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA8RPXBH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDX","IE0004445239.USD","LU0965509010.AUD","LU0417517546.SGD","LU0158827948.USD","LU1934455863.HKD","IYH","LU2089283258.USD","JDOC","VHT","FHLC","IE00B2B36J28.USD","TRUH","IXJ","LU1718418525.SGD","LU0820561909.HKD","PJP","PPH","BK4559","LU1732800096.USD","LU0395794307.EUR","LU1551013425.SGD","LU2089984988.USD","LU1934455194.USD","LU1670628061.USD","RXL","ABBV","GLAM","FTXH","LU0432979614.USD","LU1037948897.HKD","IE0002141913.USD","IE00BFTCPJ56.SGD","LU1983299246.USD","XLV","LU1244550221.USD","LU0203347892.USD","LU0553294199.USD","LU1496350502.SGD","IE00B42XCP33.USD","LU2347655156.SGD","LU0472753341.HKD","IE00B3PB1722.GBP","LU0122379950.USD","LU1093756168.USD","AGNG","LU1244550577.SGD","LU0795875169.SGD","LU2237443549.SGD","IE000BZT7R73.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666595401","title":"Abbvie Extends Migraine Leadership with Positive Phase 3 Atogepant Results in Menstrual Migraine","url":"https://stock-news.laohu8.com/highlight/detail?id=2666595401","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666595401?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:55","pubTimestamp":1789044900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA8RPXBH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0823416689.USD","RXL","BK4581","LU1934455863.HKD","LU1989772923.USD","LU0661504455.SGD","LU0949170772.SGD","GLAM","LU0128525929.USD","LU2357627491.SGD","XLV","MEDX","VHT","IYH","LU0256863811.USD","FTXH","LU1236620834.HKD","BK4588","IE000MB6IJN5.SGD","PPH","LU0859254822.USD","LU0726765562.USD","LU1057294990.SGD","IE00B2B36J28.USD","IE0000B7K699.USD","LU0203345920.USD","LU0553294199.USD","LU0170899867.USD","LU0289739699.SGD","LU2237443465.HKD","IE00BSNM7G36.USD","LU0965508806.USD","PJP","BK4534","IE00BN8TJ469.HKD","TRUH","ABBV","JDOC","IE00BFTCPJ56.SGD","BK4550","FHLC","LU2237443382.USD","LU0795875086.SGD","LU2089984988.USD","BK4139","LU0114720955.EUR","IXJ","IE00BBT3K403.USD","AGNG","LU1670628061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666059540","title":"Abbvie - Atogepant Shows Significant Improvements Across Multiple Endpoints Versus Placebo","url":"https://stock-news.laohu8.com/highlight/detail?id=2666059540","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666059540?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:55","pubTimestamp":1789044900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA8RPXBH:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FHLC","LU2468319806.SGD","XLV","PPH","BK4585","IXJ","JDOC","AGNG","LU0289739343.SGD","BK4534","LU1732799900.SGD","LU1989771016.USD","FTXH","VHT","LU2129689431.USD","IE00B19Z3B42.SGD","LU1496350502.SGD","LU1839511570.USD","LU0128525929.USD","LU2125909247.SGD","IE0004445239.USD","LU1983299246.USD","IE000SO60NU8.SGD","LU0417517546.SGD","IE0002141913.USD","LU0868494708.USD","IE00BVYPNW00.USD","IYH","LU0472753341.HKD","LU0545039389.USD","LU2089284900.SGD","LU1732800096.USD","RXL","IE0009355771.USD","ABBV","IE00B3PB1722.GBP","LU2237443622.USD","LU1162221912.USD","GLAM","IE00BBT3K403.USD","LU2133065610.SGD","MEDX","SG9999001440.SGD","PJP","IE0000B7K699.USD","TRUH","IE000BZT7R73.USD","LU0820561818.USD","LU1923622614.USD","LU1934455194.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666567427","title":"Kenvue Keeps Quarterly Dividend to $0.21 a Share; Payable Oct. 2 to Holders of Record Sept. 21","url":"https://stock-news.laohu8.com/highlight/detail?id=2666567427","media":"MT Newswires Live","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666567427?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:53","pubTimestamp":1789037624,"startTime":"0","endTime":"0","summary":"Kenvue Keeps Quarterly Dividend to $0.21 a Share; Payable Oct. 2 to Holders of Record Sept. 21","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GLAM","LU0029864427.USD","LU0792757196.USD","LU0889566641.SGD","LU1267930813.SGD","LU1267930573.SGD","BK4585","BK4588","LU0708994859.HKD","IE00B3T34201.USD","KVUE","LU0128525929.USD","IE00BFXG1179.USD","BK4183","RSPS","LU0310800379.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666922567","title":"Kenvue Declares Quarterly Dividend of $0.21 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2666922567","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666922567?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:45","pubTimestamp":1789037131,"startTime":"0","endTime":"0","summary":"Kenvue declares quarterly dividend of $0.21 per shareKenvue declared a quarterly cash dividend of $0.21 per common share.Dividend payable Oct. 2, 2026 to shareholders of record at the close of busines","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDLbvF9Gn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3T34201.USD","LU0889566641.SGD","LU0708994859.HKD","LU1267930573.SGD","IE00BFXG1179.USD","KVUE","GLAM","LU0310800379.SGD","LU0792757196.USD","BK4588","LU1267930813.SGD","LU0029864427.USD","LU0128525929.USD","BK4585","BK4183","RSPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666567994","title":"Kenvue - Declares Qtrly Cash Dividend of $0.21 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2666567994","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666567994?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:45","pubTimestamp":1789037100,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA7YYVJQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889566641.SGD","IE00B3T34201.USD","LU0792757196.USD","KVUE","LU0128525929.USD","BK4183","IE00BFXG1179.USD","LU1267930813.SGD","LU1267930573.SGD","BK4588","LU0310800379.SGD","RSPS","GLAM","LU0029864427.USD","LU0708994859.HKD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666539473","title":"Abbvie Exec Says Strong Balance Sheet and Long Growth Runway Allow Company to Consider Both Early- and Late-Stage Business Development Opportunities - Conf Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2666539473","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666539473?lang=en_us&edition=fundamental","pubTime":"2026-09-09 22:25","pubTimestamp":1788963943,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nFWN45113M:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2089284900.SGD","LU0122379950.USD","PPH","LU0738911758.USD","LU1732799900.SGD","BK4566","JDOC","TRUH","MEDX","SG9999003800.SGD","RXL","LU0170899867.USD","LU1236620834.HKD","LU2089984988.USD","GLAM","LU0965509010.AUD","LU0029864427.USD","ABBV","LU1989772840.SGD","LU0553294199.USD","PJP","LU0289739699.SGD","IE00BLSP4239.USD","LU0417517546.SGD","LU0708994859.HKD","LU0912757837.SGD","LU1037948541.HKD","FTXH","XLV","LU0158827948.USD","IYH","IE00B19Z3B42.SGD","AGNG","FHLC","LU0456855351.SGD","IE00BLSP4452.SGD","VHT","LU0234572021.USD","LU2237443978.SGD","SG9999011175.SGD","LU2112291526.USD","LU0689626769.HKD","LU0114720955.EUR","LU1934455277.USD","LU0882574055.USD","IXJ","IE000MB6IJN5.SGD","LU1267930490.SGD","SG9999015986.USD","LU0289961442.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}